Log in

LON:APHAlliance Pharma Share Price, Forecast & News

GBX 75.50
-0.30 (-0.40 %)
(As of 05/29/2020 04:00 PM ET)
Today's Range
Now: GBX 75.50
50-Day Range
MA: GBX 74.66
52-Week Range
Now: GBX 75.50
Volume1.39 million shs
Average Volume488,126 shs
Market Capitalization£400.46 million
P/E Ratio16.06
Dividend Yield2.33%
Alliance Pharma plc operates as a specialty pharmaceutical company in the United Kingdom, rest of Europe, and internationally. The company acquires, markets, and sells pharmaceutical products. It acquires the rights of established products, and owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The company also provides prescription only medicines, over the counter medications, cosmetics, and nutritional supplements, as well as medical devices. In addition, it offers products in various therapeutic areas, including acquired healthcare, cardiovascular, central nervous system, child health, consumer health, dermatology, endocrinology, gastroenterology, obstetrics and gynecology, oral health, oncology, stoma care, toxicology, travel health, urology, vitamins and minerals, and others. Further, the company provides the Kelo-Cote, a formula silicone treatment used for prevention and forming of scars; MacuShield, an eye care supplement; and Vamousse, a pesticide free consumer healthcare product for prevention and treatment of human heal lice. The company distributes its products through wholesalers, retail pharmacies, hospitals, and network of distributors. Alliance Pharma plc was founded in 1996 and is headquartered in Chippenham, the United Kingdom.
Read More
Alliance Pharma logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.07 out of 5 stars

Industry, Sector and Symbol

Industry Drugs - Generic



Sales & Book Value

Annual Sales£135.64 million
Cash FlowGBX 3.40 per share
Book ValueGBX 51.80 per share



Market Cap£400.46 million
Next Earnings DateN/A

Receive APH News and Ratings via Email

Sign-up to receive the latest news and ratings for APH and its competitors with MarketBeat's FREE daily newsletter.

Alliance Pharma (LON:APH) Frequently Asked Questions

How has Alliance Pharma's stock been impacted by COVID-19 (Coronavirus)?

Alliance Pharma's stock was trading at GBX 73 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, APH stock has increased by 3.4% and is now trading at GBX 75.50. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Alliance Pharma?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alliance Pharma in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Alliance Pharma.

How often does Alliance Pharma pay dividends? What is the dividend yield for Alliance Pharma?

Alliance Pharma announced a dividend on Tuesday, September 24th. Investors of record on Thursday, December 19th will be given a dividend of GBX 0.54 per share on Friday, January 10th. This represents a dividend yield of 0.73%. The ex-dividend date of this dividend is Thursday, December 19th. The official announcement can be viewed at this link. View Alliance Pharma's dividend history.

Has Alliance Pharma been receiving favorable news coverage?

Media coverage about APH stock has been trending extremely negative on Sunday, according to InfoTrie. The research firm ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Alliance Pharma earned a daily sentiment score of -4.6 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutAlliance Pharma.

Who are some of Alliance Pharma's key competitors?

What other stocks do shareholders of Alliance Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alliance Pharma investors own include Editas Medicine (EDIT), RPC Group (RPC), BlackBerry (BB), 1-800-Flowers.Com (FLWS), American Airlines Group (AAL), Air Canada (AC), Ally Financial (ALLY), Aviva (AV), BAE Systems (BA) and Berry Global Group (BERY).

Who are Alliance Pharma's key executives?

Alliance Pharma's management team includes the following people:
  • Mr. Peter Jonathan Butterfield, CEO & Exec. Director (Age 43)
  • Mr. John Dawson, Founder & Non-Exec. Director (Age 70)
  • Mr. Andrew Timothy Franklin, CFO & Exec. Director (Age 53)
  • Mr. Stephen Kidner, Chief Scientific & Operations Officer
  • Mr. Daniel Thomas, Chief Corp. Devel. Officer

What is Alliance Pharma's stock symbol?

Alliance Pharma trades on the London Stock Exchange (LON) under the ticker symbol "APH."

How do I buy shares of Alliance Pharma?

Shares of APH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Alliance Pharma's stock price today?

One share of APH stock can currently be purchased for approximately GBX 75.50.

How big of a company is Alliance Pharma?

Alliance Pharma has a market capitalization of £400.46 million and generates £135.64 million in revenue each year. Alliance Pharma employs 200 workers across the globe.

What is Alliance Pharma's official website?

The official website for Alliance Pharma is www.alliancepharma.co.uk.

How can I contact Alliance Pharma?

Alliance Pharma's mailing address is Avonbridge House, Bath Road, CHIPPENHAM, SN15 2BB, United Kingdom. The company can be reached via phone at +44-1249-466966.

This page was last updated on 5/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.